Related Experiment Video
Updated: Apr 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Arterial Stiffness and Renal Replacement Therapy: A Controversial Topic.
Edmundo Cabrera Fischer1, Yanina Zócalo2, Cintia Galli1
1Favaloro University (AIDUF-CONICET), Solís 453, C1078AAI Buenos Aires, Argentina ; Technological National University, C1179AAQ Buenos Aires, Argentina.
Arterial stiffness, measured by pulse wave velocity (PWV), is crucial for predicting mortality in end-stage renal disease patients. This review analyzes conflicting PWV data in dialysis patients to clarify arterial stiffness and renal replacement therapy effects.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Vascular Physiology
Background:
- Arterial stiffness significantly impacts mortality prediction in end-stage renal disease (ESRD) patients.
- Pulse wave velocity (PWV) is a reliable, noninvasive measure of regional arterial stiffness and cardiovascular mortality risk.
- Existing literature on PWV in dialysis patients presents contradictory findings regarding arterial wall stiffness changes.
Purpose of the Study:
- To systematically review and analyze existing literature on arterial stiffness in patients undergoing renal replacement therapy (RRT).
- To characterize arterial stiffness patterns in hemodialysis and peritoneal dialysis patients.
- To evaluate the responsiveness of arterial stiffness to RRT.
Main Methods:
- Literature search for longitudinal and transversal studies involving hemodialysis and/or peritoneal dialysis patients.
- Analysis of reported data on pulse wave velocity (PWV) as a measure of arterial stiffness.
- Synthesis of findings to identify consistent trends and discrepancies in arterial stiffness measurements.
Main Results:
- Contradictory reports exist regarding PWV changes in dialysis patients: some indicate increases, others decreases.
- Inconsistent findings include reports of aortic PWV augmentation concurrent with brachial artery PWV reduction.
- Variability in results may stem from differences in study design, patient populations, and measurement techniques.
Conclusions:
- Further research is needed to reconcile conflicting data on arterial stiffness in dialysis patients.
- A clearer understanding of arterial stiffness dynamics is essential for improving cardiovascular risk prediction and management in ESRD.
- Standardized methodologies for PWV assessment in RRT patients are recommended.
Related Concept Videos
Continuous Renal Replacement Therapy
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Heart Failure VI: Adjunct Therapies
Antihypertensive Drugs: Direct Renin Inhibitors

